[OUR EXPERIENCE  WITH INTERAARTERIAL THERAPEUTICS IN ARTERIOPATHIES OF THE LOWER EXTREMITIES].
D000900:Anti-Bacterial Agents; D000925:Anticoagulants; D001162:Arteriosclerosis Obliterans; D003925:Diabetic Angiopathies; D004088:Dihydroergotoxine; D004876:Ergot Alkaloids; D005341:Fibrinolysin; D005734:Gangrene; D006493:Heparin; D006801:Humans; D007263:Infusions, Parenteral; D007269:Injections, Intra-Arterial; D035002:Lower Extremity; D013923:Thromboembolism; D014652:Vascular Diseases; D014665:Vasodilator Agents
D000900:Anti-Bacterial Agents; D000925:Anticoagulants; D004876:Ergot Alkaloids; D014665:Vasodilator Agents; D004088:Dihydroergotoxine; D006493:Heparin; D005341:Fibrinolysin
ANTIBIOTICS; ANTICOAGULANTS; ARTERIOSCLEROSIS OBLITERANS; DIABETIC ANGIOPATHIES; ERGOT ALKALOIDS, HYDROGENATED; FIBRINOLYSIN; GANGRENE; HEPARIN; INFUSIONS, PARENTERAL; INJECTIONS, INTRA-ARTERIAL; THROMBOEMBOLISM; VASCULAR DISEASES; VASODILATOR AGENTS
NUESTRA EXPERIENCIA CON LA TERAPEUTICA INTRAARTERIAL EN LAS ARTERIOPATIAS  DE LOS MIEMBROS INFERIORES.